European Journal of Medicinal Chemistry p. 268 - 286 (2017)
Update date:2022-08-15
Topics:
Deshpande, Anil M.
Bhuniya, Debnath
De, Siddhartha
Dave, Bhavesh
Vyavahare, Vinod P.
Kurhade, Santosh H.
Kandalkar, Sachin R.
Naik, Keshav P.
Kobal, Balasaheb S.
Kaduskar, Rahul D.
Basu, Sujay
Jain, Vaibhav
Patil, Pratima
Chaturvedi Joshi, Sandhya
Bhat, Ganesh
Raje, Amol A.
Reddy, Satyanarayana
Gundu, Jayasagar
Madgula, Vamsi
Tambe, Suhas
Shitole, Prasad
Umrani, Dhananjay
Chugh, Anita
Palle, Venkata P.
Mookhtiar, Kasim A.
Glucokinase activators (GKAs) are among the emerging drug candidates for the treatment of type 2 diabetes (T2D). Despite effective blood glucose lowering in clinical trials, many pan-GKAs “acting both in pancreas and liver” have been discontinued from cli
View MoreZhangJiaGang YaRui Chemical Co.,Ltd.
Contact:0512-58360968
Address:China JiangSu Province Zhang Jia Gang City YangShe Oriental Plaza Building 10 B307
Beijing Century Richap Chemistry Co.,Ltd
Contact:+86- 010-64455497
Address:Guannan County, Lianyungang City, Jiangsu Province, China
NANCHANG QINZHI SCI&TEC.CO.,LTD
Contact:+86-13687004106
Address:Hero South Road,Hero Zone,Nanchang,Jiangxi,China
website:https://www.bocsci.com/
Contact:1-631-485-4226
Address:Ramsey Road
Goldwills Pharmaceuticals Co., Ltd.
Contact:0916-2237889 13991621155
Address:North Suburb of Hanzhong city, Shaanxi Province
Doi:10.1002/asia.201100145
(2011)Doi:10.1021/jm200647u
(2011)Doi:10.1021/jm9903949
(1999)Doi:10.1039/b900164f
(2009)Doi:10.1002/asia.201100174
(2011)Doi:10.1016/S0040-4020(01)89069-4
(1990)